LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$1.72
+0.08 (+4.88%)
Open$1.63
Previous Close$1.64
Day High$1.77
Day Low$1.63
52W High$1.83
52W Low$0.31
Volume—
Avg Volume2.58M
Market Cap678.22M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+944.8% upside
Current
$1.72
$1.72
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 40.90M | 68.34M | 62.90M |
| Net Income | -263,791,495 | 19.40M | 18.23M |
| Profit Margin | -644.8% | 28.4% | 29.0% |
| EBITDA | -242,602,238 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +369.7% | +10.7% | +9.3% |
| Debt/Equity | 0.69 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |